Pharming Group (PHAR) News Today $8.72 -0.12 (-1.30%) As of 02:49 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOwnershipSEC FilingsShort InterestTrendsBuy This Stock All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 Time Period Pharming Group (NASDAQ:PHAR) Trading Down 2% - Here's WhyPharming Group (NASDAQ:PHAR) Shares Down 2% - Here's What HappenedMarch 25 at 12:26 PM | marketbeat.comPharming Group (NASDAQ:PHAR) Shares Gap Down - Here's WhyPharming Group (NASDAQ:PHAR) Shares Gap Down - What's Next?March 22 at 12:32 PM | marketbeat.comPharming Group (NASDAQ:PHAR) Earns "Buy" Rating from HC WainwrightMarch 22 at 3:35 AM | americanbankingnews.comHC Wainwright Reiterates "Buy" Rating for Pharming Group (NASDAQ:PHAR)HC Wainwright reaffirmed a "buy" rating and issued a $37.00 target price on shares of Pharming Group in a report on Thursday.March 21, 2025 | marketbeat.comPharming Group (NASDAQ:PHAR) Sees Strong Trading Volume - Here's WhyPharming Group (NASDAQ:PHAR) Sees Strong Trading Volume - Should You Buy?March 20, 2025 | marketbeat.comPharming Group Begins Phase II Trial for CVID TreatmentMarch 20, 2025 | tipranks.comPharming Group (NASDAQ:PHAR) Trading Down 3.6% - What's Next?Pharming Group (NASDAQ:PHAR) Trading Down 3.6% - Should You Sell?March 18, 2025 | marketbeat.comPharming Group's (PHAR) Buy Rating Reiterated at HC WainwrightMarch 17, 2025 | americanbankingnews.comWhat Analysts Are Saying About Pharming StockMarch 17, 2025 | benzinga.comPharming Group (NASDAQ:PHAR) Price Target Raised to $39.00 at OppenheimerOppenheimer lifted their target price on Pharming Group from $30.00 to $39.00 and gave the company an "outperform" rating in a research report on Friday.March 15, 2025 | marketbeat.comPharming Group's (PHAR) Buy Rating Reaffirmed at HC WainwrightHC Wainwright reissued a "buy" rating and issued a $37.00 target price on shares of Pharming Group in a research note on Friday.March 15, 2025 | marketbeat.comPharming Group (NASDAQ:PHAR) Shares Gap Up - Here's WhyPharming Group (NASDAQ:PHAR) Shares Gap Up - Here's WhyMarch 14, 2025 | marketbeat.comPharming Group (NASDAQ:PHAR) Releases Earnings Results, Misses Estimates By $0.02 EPSPharming Group (NASDAQ:PHAR - Get Free Report) issued its quarterly earnings results on Thursday. The company reported $0.05 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $0.07 by ($0.02). Pharming Group had a negative net margin of 6.09% and a negative return on equity of 7.65%.March 14, 2025 | marketbeat.com3 European Penny Stocks With Market Caps Over €300MMarch 14, 2025 | uk.finance.yahoo.comPharming Group (NASDAQ:PHAR) Short Interest UpdatePharming Group (NASDAQ:PHAR - Get Free Report) saw a large drop in short interest in the month of February. As of February 28th, there was short interest totalling 2,800 shares, a drop of 47.2% from the February 13th total of 5,300 shares. Currently, 0.0% of the shares of the stock are short sold. Based on an average daily volume of 7,100 shares, the days-to-cover ratio is currently 0.4 days.March 14, 2025 | marketbeat.comPharming Group (PHGUF) Q4 2024 Earnings Call Highlights: Strong Revenue Growth and Strategic ...March 14, 2025 | gurufocus.comPharming Group outlines 2025 revenue guidance of $315M to $335M driven by RUCONEST and Joenja growthMarch 14, 2025 | msn.comPharming Group Full Year 2024 Earnings: EPS Beats ExpectationsMarch 14, 2025 | uk.finance.yahoo.comQ4 2024 Pharming Group NV Earnings Call TranscriptMarch 14, 2025 | gurufocus.comPharming Group N.V. (PHAR) Q4 2024 Earnings Call TranscriptMarch 13, 2025 | seekingalpha.comPharming Group reports fourth quarter and full year 2024 financial results and provides business updateMarch 13, 2025 | markets.businessinsider.comPharming Group (NASDAQ:PHAR) Shares Up 6.3% - Here's WhyPharming Group (NASDAQ:PHAR) Trading 6.3% Higher - Here's What HappenedMarch 12, 2025 | marketbeat.comPharming Group (NASDAQ:PHAR) Sees Strong Trading Volume - Here's What HappenedPharming Group (NASDAQ:PHAR) Sees Strong Trading Volume - Time to Buy?March 8, 2025 | marketbeat.comPharming Group (NASDAQ:PHAR) Shares Gap Down - Time to Sell?Pharming Group (NASDAQ:PHAR) Shares Gap Down - Should You Sell?March 6, 2025 | marketbeat.comPharming Group (PHAR) Expected to Announce Earnings on ThursdayPharming Group (NASDAQ:PHAR) will be releasing earnings before the market opens on Thursday, March 13, Financial Modeling Prep reports.March 6, 2025 | marketbeat.comPharming Group (NASDAQ:PHAR) Trading Down 4.9% - Time to Sell?Pharming Group (NASDAQ:PHAR) Stock Price Down 4.9% - Time to Sell?March 5, 2025 | marketbeat.comPharming Group Appoints New CEO to Strengthen Market PositionMarch 4, 2025 | tipranks.comPharming Group (NASDAQ:PHAR) Shares Up 6.6% - What's Next?Pharming Group (NASDAQ:PHAR) Trading 6.6% Higher - Here's WhyMarch 3, 2025 | marketbeat.comShort Interest in Pharming Group (NASDAQ:PHAR) Declines By 29.3%Pharming Group (NASDAQ:PHAR - Get Free Report) was the target of a large decline in short interest in February. As of February 15th, there was short interest totalling 5,300 shares, a decline of 29.3% from the January 31st total of 7,500 shares. Based on an average daily volume of 6,600 shares, the days-to-cover ratio is currently 0.8 days.March 3, 2025 | marketbeat.comPharming Group (NASDAQ:PHAR) Shares Gap Up - What's Next?Pharming Group (NASDAQ:PHAR) Shares Gap Up - Time to Buy?March 1, 2025 | marketbeat.comPharming Group to participate in March investor conferenceFebruary 28, 2025 | finance.yahoo.comPharming Group N.V.: Pharming Group to report fourth quarter and full year 2024 financial results on March 13February 27, 2025 | finanznachrichten.dePharming Group to report fourth quarter and full year 2024 financial results on March 13February 27, 2025 | finance.yahoo.comAbliva AB: Abliva applies for delisting and will convene an extraordinary general meetingFebruary 25, 2025 | finanznachrichten.dePharming Group (NASDAQ:PHAR) Trading 6.2% Higher - Here's WhyPharming Group (NASDAQ:PHAR) Stock Price Up 6.2% - Here's WhyFebruary 24, 2025 | marketbeat.comPharming Group (NASDAQ:PHAR) Short Interest Down 68.4% in JanuaryPharming Group (NASDAQ:PHAR - Get Free Report) was the recipient of a significant drop in short interest in January. As of January 31st, there was short interest totalling 7,500 shares, a drop of 68.4% from the January 15th total of 23,700 shares. Based on an average daily volume of 7,200 shares, the days-to-cover ratio is presently 1.0 days.February 12, 2025 | marketbeat.comPharming Group (NASDAQ:PHAR) Sees Large Volume Increase - Should You Buy?Pharming Group (NASDAQ:PHAR) Sees Strong Trading Volume - Still a Buy?February 11, 2025 | marketbeat.comHigh Growth Tech And These 3 Dynamic Stocks with Promising ExpansionFebruary 11, 2025 | finance.yahoo.comPharming Completes Acquisition of Abliva SharesFebruary 7, 2025 | tipranks.comPharming Technologies B.V. declares unconditional and completes the recommended cash offer to the shareholders of Abliva AB (publ) and extends the acceptance periodFebruary 7, 2025 | globenewswire.comPharming Group (NASDAQ:PHAR) Trading 5.7% Higher - Here's WhyPharming Group (NASDAQ:PHAR) Trading Up 5.7% - Here's What HappenedFebruary 6, 2025 | marketbeat.comPharming Group (NASDAQ:PHAR) Sees Large Volume Increase - Here's WhyPharming Group (NASDAQ:PHAR) Sees Unusually-High Trading Volume - Should You Buy?February 5, 2025 | marketbeat.comPharming Group (NASDAQ:PHAR) Trading Down 7.8% - Time to Sell?Pharming Group (NASDAQ:PHAR) Trading Down 7.8% - Should You Sell?February 3, 2025 | marketbeat.comPharming Group (NASDAQ:PHAR) Sees Unusually-High Trading Volume - Still a Buy?Pharming Group (NASDAQ:PHAR) Sees Large Volume Increase - Time to Buy?January 29, 2025 | marketbeat.comPharming Group (NASDAQ:PHAR) Shares Up 5.4% - Should You Buy?Pharming Group (NASDAQ:PHAR) Stock Price Up 5.4% - Should You Buy?January 28, 2025 | marketbeat.comPharming Group (NASDAQ:PHAR) Shares Gap Up - Should You Buy?Pharming Group (NASDAQ:PHAR) Shares Gap Up - Still a Buy?January 24, 2025 | marketbeat.comPharming Group (NASDAQ:PHAR) Sees Unusually-High Trading Volume - What's Next?Pharming Group (NASDAQ:PHAR) Sees Large Volume Increase - What's Next?January 22, 2025 | marketbeat.comPharming to nominate Fabrice Chouraqui as new CEO, succeeding Sijmen de VriesJanuary 21, 2025 | markets.businessinsider.comPharming Group Announces EGM for Leadership TransitionJanuary 21, 2025 | tipranks.comPharming Group appoints former Novartis USA President Fabrice Chouraqui as New CEOJanuary 21, 2025 | msn.com Remove Ads Get Pharming Group News Delivered to You Automatically Sign up to receive the latest news and ratings for PHAR and its competitors with MarketBeat's FREE daily newsletter. Email Address PHAR Media Mentions By Week PHAR Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. PHAR News Sentiment▼0.500.68▲Average Medical News Sentiment PHAR News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. PHAR Articles This Week▼83▲PHAR Articles Average Week Remove Ads Get Pharming Group News Delivered to You Automatically Sign up to receive the latest news and ratings for PHAR and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies MIRM News Today EWTX News Today CNTA News Today KYMR News Today CGON News Today DNLI News Today BLTE News Today ARWR News Today ARQT News Today TARS News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:PHAR) was last updated on 3/25/2025 by MarketBeat.com Staff From Our PartnersYour Wealth is Under AttackPlease don't wait—this is your moment to take action. Download your Wealth Protection Guide now, claim your fr...American Alternative | SponsoredA brutally honest economic warning for 2025 (see proof)New York Times best-selling financial author and world-renowned economist Addison Wiggin (a man who’s worked s...Banyan Hill Publishing | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredHas Trump finally met his match?Dylan Jovine predicted the 2008 crash over a year before it happened. Folks who listened to him had the chance...Behind the Markets | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredDOGE officially begins retirement transformationElon Musk's Department of Government Efficiency ("DOGE") just announced the first-ever "fully digital retireme...Altimetry | Sponsored“Amazon Coin” set to outperform BitcoinChris Rowe – the man who recommended Amazon in 1998… Bitcoin and Ethereum in 2017… And has spotted 44 diffe...True Market Insiders | SponsoredEx CIA predicts 40% “double crash” – April 11The scientists here don’t study deadly viruses… directed energy weapons… or even weather control technology… ...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Pharming Group Please log in to your account or sign up in order to add this asset to your watchlist. Share Pharming Group With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
